- Country: Russia
- Summary: Supply of a Medicinal Product for Medical Use with the International Nonproprietary Name Ceftriaxone for the Needs of the Nerekhta Central Regional Hospital
- RUT Ref No: 131139894
- Deadline: 08 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: 245000.00
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of a Medicinal Product for Medical Use with the International Nonproprietary Name Ceftriaxone for the Needs of the Nerekhta Central Regional Hospital - Russia Tender
The REGIONAL STATE BUDGET HEALTH INSTITUTION "NEREKHTA CENTRAL DISTRICT HOSPITAL, a Government sector organization in Russia, has announced a new tender for Supply of a Medicinal Product for Medical Use with the International Nonproprietary Name Ceftriaxone for the Needs of the Nerekhta Central Regional Hospital. This tender is published on RussiaTenders under RUT Ref No: 131139894 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-08.
The estimated tender value is 245000.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
